Ankeny-based Embria Health Sciences has expanded the market for its fermented immune supplement ingredient EpiCor into Central and Eastern Europe with a new distribution agreement with Hermes Consilium. Through this agreement Hermes Consilium will be the exclusive sales agent for EpiCor in 10 countries: Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Slovenia, Croatia, Serbia and Macedonia. “Embria continues to expand internationally, and we have seen sales continue to grow exponentially overseas,” said Jeff Cannon, CEO of Embria’s parent company, Diamond V.